Did your doctor offer "prophylatic" GCSF with your Adcetris treatment? New data says they should..

byMedMaven

Feb 9, 2019

Comments (1)

No. 1-1

MedMaven

Editor

Feb 9, 2019

Adcetris Combination with Chemotherapy-New Standard of Care for Hodgkin Lymphoma - news.cancerconnect.com

Adcetris + AVD Chemotherapy further improved with prophylatic G-CSF to maintain dose and prevent fever and infection

news.cancerconnect.com

Overview of Hodgkin's Lymphoma

Overview, Symptoms, Diagnosis, Evaluation, & Screening & Prevention of Hodgkin's lymphoma

Cancer Connect

Nov 1, 2019

Treatment & Management of Hodgkin Lymphoma

Precision cancer medicines and immunotherapy are improving outcomes for individuals with Hodgkin lymphoma.

Cancer Connect

Nov 2, 2019

Treatment for Stages I - IIA Hodgkin Lymphoma

Treatment of Stages I - IIA Hodgkins Lymphoma

Cancer Connect

Nov 1, 2019

Caring for Yourself During Chemotherapy for Hodgkin’s Lymphoma

Caring for Yourself During Chemotherapy for Hodgkin’s Lymphoma: How to Manage Hair Loss, Dry Skin, and Brittle Nails

Cancer Connect

Jan 10

Hodgkin’s Survivors: Increased Fatigue, Cardiac, and Thyroid Complications

HL: Be aware of longer term complications and issues.

Cancer Connect

Jan 9

Recurrent Hodgkin Lymphoma Treatment With Adcetris

The precision cancer medicine Adcetris is changing the way recurrent Hodgkin lymphoma is managed.

MedMaven

Apr 29, 2019

Treatment for Stage IIB - IV A or B Hodgkin Lymphoma

Treatment of stages IIB - IV A or B Hodgkin lymphoma: Adcetris + AVD is a new standard of care.

Cancer Connect

Nov 1, 2019

Adcetris Combination with Chemotherapy-New Standard of Care for Hodgkin Lymphoma

Adcetris + AVD and G-CSF significantly improves outcomes compared to ABVD - 4 years follow up.from ASH 2019.

Cancer Connect

Dec 12, 2019

Risk of Second Cancers After Hodgkin’s Lymphoma Is Similar Across Treatment

HL survivors at increased risk of developing new cancers and other long term side effects.

Cancer Connect

Jan 2

Opdivo Immunotherapy for Hodgkin's Lymphoma

PD-1 Immunotherapy gaining traction in HL - ASH 2019 data demonstrates effectives as "Bridge" to ASCT.

Cancer Connect

Dec 26, 2019

Cancer Connect

theRAconnection

The Spine Community

Women's Health

Osteoporosis